IQ-AI Limited enters into a global distribution partnership with AI Metrics, LLC

  • Jan 09, 2020 GMT
  • Team Kalkine
IQ-AI Limited (LON: IQAI) has entered into a global distribution partnership with AI Metrics, LLC.
  • The company has stated that the agreement grants it non-exclusive global rights to market and distribute AI Metrics' liver surface nodularity (LSN) image analysis product.
  • LSN is a first-to-market platform designed by AI Metrics as a virtual liver biopsy, evaluating it to assess Chronic Liver Disease (CLD) using commonly acquired CT images.
  • The company has also offered its regulatory expertise and is assisting AI Metrics in obtaining CE Mark and FDA 510(k) market clearance in Europe and the U.S., respectively.
  • On 9th January 2020, at the time of writing, GMT 08:01 AM, IQAI shares were trading at GBX 5.05, up by 0.25 points or 5.21% against the previous day closing price.

With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities. 

Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?

Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.

We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.

To know more about these dividend stocks, click here

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK